Melanie Neary, Branden Berns, and Ryan Murr of Gibson Dunn, along with Bud O’Hara of Jefferies, hosted a Life Sciences 2025 Outlook: Capital Markets webcast on Wednesday, March 19, 2025, breaking down capital market trends, deal activity, and industry expectations for life sciences in 2025.
In addition to providing a recap of 2024 transactions, panelists discussed how 2025 market performance and deal activity compare to initial expectations for the year. Panelists discussed timely topics such as:
- SEC and the New Administration – How potential regulatory shifts could impact capital formation
- Biotech Valuations – Trends in market cap and enterprise value, plus their ripple effects
- Deal Structures in Volatile Markets – Why PIPE transactions and reverse mergers can provide stability in otherwise choppy markets
Please visit https://www.gibsondunn.com/webcast-life-sciences-2025-outlook-webcast-series-capital-markets for a recording of the webcast as well as a copy of the slides.
Thanks to Jefferies for joining us for this webcast.